Literature DB >> 929513

Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors.

F E Preston, R C Dinsdale, D J Sutcliffe, G Bardhan, P J Wyld, J F Hamlyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 929513     DOI： 10.1016/0049-3848(77)90022-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

Review 1.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.

Authors:  D H Parry; A L Bloom
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

Review 3.  Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors.

Authors:  Geir E Tjønnfjord; Pål Andre Holme
Journal:  Vasc Health Risk Manag       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.